Australian Life Sciences Stock News

Nova Minerals (ASX:NVA) just wrapped up a roughly A$20 million follow on equity offering in its American Depositary Shares, a capital raise that directly shapes how it funds the next phase of its growth plans. See our latest analysis for Nova Minerals. The fresh capital raise lands after a busy few weeks, including a US shelf registration and conference appearance. It comes as Nova’s 90 day share price return of 152.11 percent and 1 year total shareholder return of 179.69 percent signal...

Aeris Resources (ASX:AIS) has just wrapped up a follow on equity offering, raising about A$21.6 million by issuing nearly 48 million new ordinary shares at A$0.45, reshaping its balance sheet. See our latest analysis for Aeris Resources. That capital raise lands after a powerful run, with the latest A$0.535 quote coming off a roughly 46 percent 3 month share price return and a near tripling year to date. Longer term total shareholder returns remain more muted, so momentum still looks firmly...

Paladin Energy has completed a restructure of its syndicated debt facility with Nedbank and Macquarie, trimming overall capacity from US$150 million to US$110 million to better match its stronger liquidity after 2025 equity raises. The revised facility increases undrawn debt capacity and balance sheet flexibility as Paladin advances the ramp-up of its Langer Heinrich Mine, underscoring management’s focus on funding growth without over-reliance on borrowings. We’ll now explore how this...

ANZ Group Holdings (ASX:ANZ) has been grinding higher this year, and with the share price hovering around A$36, investors are weighing whether the recent climb still leaves room for steady upside. See our latest analysis for ANZ Group Holdings. Over the past year, ANZ has quietly turned in a strong run, with solid year to date share price gains and an impressive multi year total shareholder return that signals momentum is still very much on its side. If ANZ's steady climb has you thinking...

ALS (ASX:ALQ) has just lodged an application to quote 342,915 new fully paid ordinary shares issued under its dividend or distribution plan. It is a relatively small move that still speaks directly to capital management. See our latest analysis for ALS. The fresh shares land against a backdrop of firm momentum, with ALS’s share price at A$22.12 and a strong year to date share price return supported by robust multi year total shareholder returns, which suggests that confidence in its growth...

While Ausgold Limited ( ASX:AUC ) shareholders have had a good week with the stock up 17%, insiders can't say the same...

David Iben put it well when he said, 'Volatility is not a risk we care about. What we care about is avoiding the...

With a price-to-earnings (or "P/E") ratio of 24.5x MAAS Group Holdings Limited ( ASX:MGH ) may be sending bearish...

Investing can be hard but the potential fo an individual stock to pay off big time inspires us. But when you hold the...

Key Insights Waratah Minerals' significant retail investors ownership suggests that the key decisions are influenced by...

When a single insider purchases stock, it is typically not a major deal. However, when multiple insiders purchase...

In December 2025, Telix Pharmaceuticals updated investors on the progression of its ProstACT Global Phase 3 trial for TLX591 in metastatic castration‑resistant prostate cancer and announced a new clinical collaboration with Varian to combine its prostate theranostics with external beam radiation therapy. These developments come as Telix works to expand its prostate cancer platform globally while managing regulatory setbacks and class action lawsuits over alleged misstatements on clinical...

Key Insights Sonic Healthcare's significant individual investors ownership suggests that the key decisions are...

Sunrise Energy Metals Limited ( ASX:SRL ) insiders who purchased shares in the last 12 months were richly rewarded last...

Last week, Sprintex Limited ( ASX:SIX ) insiders, who had purchased shares in the previous 12 months were rewarded...

In the last year, many Generation Development Group Limited ( ASX:GDG ) insiders sold a substantial stake in the...

Flight Centre Travel Group Limited ( ASX:FLT ) shareholders have had their patience rewarded with a 27% share price...

Key Insights Institutions' substantial holdings in Bega Cheese implies that they have significant influence over the...

By buying an index fund, you can roughly match the market return with ease. But many of us dare to dream of bigger...

The board of APA Group ( ASX:APA ) has announced that it will pay a dividend of A$0.275 per share on the 18th of March...

Did you know there are some financial metrics that can provide clues of a potential multi-bagger? One common approach...

Megaport (ASX:MP1) has had a choppy few months, but its longer term returns and rapid revenue and earnings growth are drawing fresh attention from investors who are trying to gauge whether the current pullback offers value. See our latest analysis for Megaport. At A$12.59, Megaport’s recent pullback, including a weaker 90 day share price return, sits in sharp contrast to its strong year to date share price momentum and impressive multi year total shareholder returns. This suggests sentiment...

Boss Energy (ASX:BOE) has jolted investors by withdrawing its 2021 Honeymoon uranium feasibility study after a major review flagged less favourable mineralisation and higher long term costs, sending the stock sharply lower and putting the project back under the microscope. See our latest analysis for Boss Energy. The Honeymoon downgrade caps a rough stretch for shareholders, with a year to date share price return of around negative 47% and a one year total shareholder return of about negative...

Codan Limited recently came under pressure after a broker shifted to a more cautious stance, reflecting concerns about how the company is currently valued despite previously strong first-half FY25 results. This shift, combined with bearish technical patterns and more cautious investor sentiment, has raised fresh questions about how durable Codan’s recent operational momentum may prove. We’ll now examine how the broker downgrade on valuation grounds might influence Codan’s existing investment...